{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:39:53Z","timestamp":1787013593818,"version":"build-2736575974"},"reference-count":81,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bullous pemphigoid (BP) is an autoimmune blistering disease associated with anti\u2010BP180 and anti\u2010BP230 antibodies. The pathogenic action mechanism of immunoglobulin E (IgE) antibodies in BP has been studied since the 1970s, and IgE antibodies have gradually been confirmed as being important in BP; therefore, anti\u2010IgE therapy may be a new option for the treatment of BP. Omalizumab, as an IgE monoclonal antibody, has been increasingly used clinically to treat BP in recent years. Here, we collected 35 papers investigating omalizumab for BP treatment in a total of 83 patients, and the vast majority of patients showed varying degrees of improvement after treatment, except for a small number of patients with poor clinical outcomes. The patients were then divided into three groups according to dosing frequency and number of doses. Statistical analysis indicated that dosing frequency had little effect on clinical efficacy. While the groups with different numbers of doses were evaluated, the results concluded that clinical efficacy was affected by the number of doses, but there was no positive correlation between the number of doses and clinical efficacy.<\/jats:p>","DOI":"10.1111\/1346-8138.16791","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T06:05:54Z","timestamp":1679897154000},"page":"575-587","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Research progress of omalizumab in the treatment of bullous pemphigoid"],"prefix":"10.1111","volume":"50","author":[{"given":"Xiaoya","family":"Ling","sequence":"first","affiliation":[{"name":"The First Clinical Medical College of Zhejiang Chinese Medicine University 310053 Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Shou","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Zhejiang Chinese Medicine University 310053 Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Lou","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Zhejiang Chinese Medicine University 310053 Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ling","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Zhejiang Chinese Medicine University 310053 Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Zhejiang Chinese Medicine University 310053 Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugen","family":"Yu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine (Zhejiang Province Hospital of Chinese Medicine) Hangzhou 310006 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-0981","authenticated-orcid":false,"given":"Weijia","family":"Gu","sequence":"additional","affiliation":[{"name":"School of Public Health Zhejiang Chinese Medical University Hangzhou 310053 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11108.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13660"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2018.30.1.13"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4556"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20743"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2022.07.005"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.032"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.12.001"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01720.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2018.12.007"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12337492"},{"key":"e_1_2_8_14_1","first-page":"193","article-title":"Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin","volume":"18","author":"Provost TT","year":"1974","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2340\/0001555564243246","article-title":"Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti\u2010basement membrane zone antibodies","volume":"64","author":"Asbrink E","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2340\/0001555565273274","article-title":"Serum IgE levels in patients with bullous pemphigoid","volume":"65","author":"Nieboer C","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001050051001"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1974.01630090016003"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10481.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8547-7"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700958"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.11.031"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1496"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2015.02.009"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2015.03.002"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12146.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2101"},{"key":"e_1_2_8_28_1","first-page":"1322","article-title":"Omalizumab\u2010 treatment of therapy resistant bullous pemphigoid","volume":"13","author":"Balakirski G","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700681"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100596"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-015-1598-3"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3357"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K005"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1248403"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2815"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2014.03.003"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02803.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215372"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/72601"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040895"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1249819"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18220"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15114"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1789-1"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.09.011"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.183628"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.11.035"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10748.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.1604"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17999"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874108"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S373682"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1159\/000452828"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.01.002"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.4274\/turkderm.65983"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03214.x"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2020.09.577"},{"key":"e_1_2_8_58_1","first-page":"2057019","article-title":"Successful Management of Acquired Hemophilia a Associated with bullous pemphigoid: a case report and review of the literature","volume":"2017","author":"Binet Q","year":"2017","journal-title":"Case Rep Hematol"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2018.3284"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2013.130642"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.04.053"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13758"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2845"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.643"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.12.015"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12829"},{"key":"e_1_2_8_67_1","first-page":"e146","article-title":"M BS, Murrell DF. 14th Annual Medical Dermatology Meeting 17th January 2019 RCP, London","volume":"180","author":"De B","year":"2019","journal-title":"Br J Dermatol"},{"key":"e_1_2_8_68_1","article-title":"Omalizumab (xolair) in treatment resistant bullous pemphigoid","volume":"60","author":"Blake S","year":"2019","journal-title":"Aust J Dermatol"},{"key":"e_1_2_8_69_1","first-page":"947","article-title":"Successful omalizumab therapy for bullous pemphigoid despite transient reaction","volume":"18","author":"Ewy S","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01919"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2018.12.114"},{"key":"e_1_2_8_72_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1684\/ejd.2019.3499","article-title":"Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab","volume":"29","author":"Maglie R","year":"2019","journal-title":"Eur J Dermatol"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.08.385"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.08.384"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.08.386"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14160"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_438_19"},{"key":"e_1_2_8_78_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/ijd.IJD_128_20","article-title":"Biologics Beyond Boundaries: Innovative Use of Biologics in Dermatology","volume":"66","author":"De A","year":"2021","journal-title":"Indian J Dermatol"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17229"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611549"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002418"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2020.08.053"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.16791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T22:55:49Z","timestamp":1729119349000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.16791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1111\/1346-8138.16791"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.16791","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"2023-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}